FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition Hide this message

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen Diesen Hinweis ausblenden

Corona rapid test from GNA Biosolutions approved

The rapid test of the Bavarian start-up is said to provide a result in less than an hour.

The German Federal Institute for Drugs and Medical Devices (BfArM) has granted special approval to the Corona rapid test developed by the Bavarian start-up GNA Biosolutions, which specialises in molecular diagnostics. The test is said to provide the correct result in 96.7 percent of cases and takes only 40 minutes. Another advantage: According to the manufacturer, decentralized laboratories are sufficient for this test.

Unlike the most commonly used rapid antigen tests, GNA Biosolutions' test is based on the PCR test and therefore provides more accurate results. The start-up uses Pulse Controlled Amplification (PCA®) technology, a new approach to polymerase chain reaction (PCR), the global standard for COVID-19 molecular testing.

Photo: GNA Biosolutions

"In order to make our technology available across Europe, we are aiming for a CE mark in the first quarter of 2021," said CEO and co-founder Dr Federico Buersgens. The start-up from Martinsried near Munich received funding from the Bavarian Ministry of Economic Affairs for its development. Now, more than 500,000 tests are to be produced.


Corona Covid-19 Schnelltest
Like it? Please spread the word:

Newsletter

Startups, Stories und Statistiken direkt in dein Postfach. Mit 2 Klicks abonnieren. Noice.

LinkedIn Connect

Take care, give care

Hat dich diese News informiert oder unterhalten? Dann würden wir uns freuen, wenn du deinem Netzwerk davon erzählst.

Auf Linkedin teilen Auf Facebook teilen Auf Xing teilen

Similar posts